You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 292 No. 7, August 18, 2004 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Research Letters
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on Web of Science (3)
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Topic Collections
 •Cardiovascular System
 •Cardiovascular Disease/ Myocardial Infarction
 •Endocrine Diseases
 •Diabetes Mellitus
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Tomato Juice and Platelet Aggregation in Type 2 Diabetes

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

To the Editor: Metabolic abnormalities in type 2 diabetes are associated with increased platelet sensitivity to proaggregants and decreased platelet sensitivity to endogenous antiaggregants.1-2 Thus, patients with type 2 diabetes have an increased risk of developing atherosclerosis and cardiovascular complications.2

Consumption of tomato products has been found to be inversely correlated with incidence of acute coronary events, development of early atherosclerosis, and mortality from heart disease.3 Furthermore, clarified tomato juice has been shown to inhibit human platelet aggregation in vitro4-5 and in an animal model.6 We examined whether consumption of tomato juice clarified by filtration could inhibit platelet aggregation in patients with type 2 diabetes or impaired glucose tolerance.

Methods

Patients with type 2 diabetes (n = 18) or impaired glucose tolerance (n = 2) without prior history of thromboembolic events were recruited from the community using media advertising. Fourteen men and 6 women aged 43 to 82 years with a . . . [Full Text of this Article]

Sheryl A. Lazarus, BS
Department of Nutrition and Dietetics
Faculty of Health
University of Newcastle

Kerry Bowen, PhD, FRACP
Diabetes Education Centre
Royal Newcastle Hospital

Manohar L. Garg, PhD, APD
manohar.garg@newcastle.edu.au
Department of Nutrition and Dietetics
Faculty of Health
University of Newcastle
Newcastle, Australia



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2004 American Medical Association. All Rights Reserved.